The Cooper Companies, Inc. with ticker code (COO) now have 13 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges between 440 and 349 with the average target price sitting at $409.62. Now with the previous closing price of $352.21 this would imply there is now a potential upside of 16.3%. It’s also worth noting that there is a 50 day moving average of $380.68 and the 200 day moving average is $358.33. The market cap for the company is 17.66B. The stock price is currently at: 356.65 USD
The potential market cap would be $20,541,788,990 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 64.38, revenue per share of 71.07 and a 2.75% return on assets.
The Cooper Companies, Inc. is a global medical device company. The Company operates through two segments: CooperVision and CooperSurgical. CooperVision segment is engaged in developing, manufacturing and marketing a range of products for contact lens wearers, featuring advanced materials and optics. CooperVision segment designs its products to solve vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigue, with a broad collection of spherical, toric and multifocal contact lenses. CooperSurgical segment focus on advancing the health of women, babies and families through a diversified portfolio of products and services focusing on women’s health and fertility. CooperSurgical segment supplies the family health care market with a diversified portfolio of products and services. Its office and surgical offerings include products that facilitate surgical and non-surgical procedures that are commonly performed primarily by obstetricians and gynecologists.
